Alpine Immune Sciences Inc (ALPN.OQ)
ALPN.OQ on NASDAQ Stock Exchange Global Market
7.85USD
1:30am IST
7.85USD
1:30am IST
Change (% chg)
$-0.16 (-2.00%)
$-0.16 (-2.00%)
Prev Close
$8.01
$8.01
Open
$8.05
$8.05
Day's High
$8.05
$8.05
Day's Low
$7.82
$7.82
Volume
1,575
1,575
Avg. Vol
6,378
6,378
52-wk High
$12.82
$12.82
52-wk Low
$6.97
$6.97
About
Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $168.94 |
| Shares Outstanding(Mil.): | 13.88 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
BRIEF-Alpine Immune Sciences Appoints Chris Peetz To Its Board
* ALPINE IMMUNE SCIENCES APPOINTS LIFE SCIENCES EXECUTIVE CHRIS PEETZ TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:
BRIEF-Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS
Estimates